Pressefach

AUSSENDER



QIAGEN N.V.
Ansprechpartner: Investor Relations
Tel.: +31 7735566 - 00
E-Mail: ir@qiagen.com
Pressefach (336)

Schlagwörter

QIAGEN N.V.
Stimmrechtsanteile
Voting rights
09.09.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
05.09.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
29.08.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
29.08.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
26.08.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
26.08.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
22.08.2025 - 11:53 | QIAGEN N.V.
Release of a capital market information
18.08.2025 - 22:00 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
18.08.2025 - 22:00 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
18.08.2025 - 22:00 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
17.08.2025 - 22:00 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
29.07.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
25.07.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
22.07.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
22.07.2025 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
zurück
Artikel 16 - 30
weiter
|
98.928 Abonnenten
|
230.626 Meldungen
|
93.253 Pressefotos
|
Folgen Sie uns auf  X
Top